81 FR 58524 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 165 (August 25, 2016)

[Federal Register Volume 81, Number 165 (Thursday, August 25, 2016)]
[Notices]
[Pages 58524-58525]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20346]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PQ 11: Mechanisms by which standard-of-care therapies affect 
immunotherapy.
    Date: September 28, 2016.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W108, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W108, Rockville, MD 20892-9750, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project II (P01).
    Date: October 4-5, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W618, 
Rockville, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PQ 1: Inhibition of tumor growth in pre-malignant fields.
    Date: October 13, 2016.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2W032/034, Rockville, MD 20850 (Telephone 
Conference Call).
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W108, Rockville, MD 20892-9750, 240-276-6343, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21: SEP-5.
    Date: October 14, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W110, Rockville, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Provocative Question 7.
    Date: October 25, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Dona Love, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W236, Rockville, 
MD 20892-9750, 240-276-5264, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Research Answers to NCI's Provocative Questions.
    Date: October 26, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Core Infrastructure and Methodological Research for Cancer 
Epidemiology Cohorts.
    Date: November 1, 2016.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 6W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, 9609 Medical Center Drive, Room 7W412, 
Rockville, MD 20892-9750, 240-276-6386, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21: SEP-2.
    Date: November 3-4, 2016.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Yisong Wang, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W240, Rockville, 
MD 20892-9750, 240-276-7157, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R01/U01 Review.
    Date: November 3, 2016.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 2E914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program

[[Page 58525]]

Review Branch, Division of Extramural Activities, National Cancer 
Institute, 9609 Medical Center Drive, Room 7W110, Rockville, MD 
20892-9750, 240-276-6344, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational Exploratory/Developmental 
Studies (R21): SEP-1.
    Date: November 7-8, 2016.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Dona Love, Ph.D., Scientific Review Officer, 
Special Review Branch, Division of Extramural Activities, National 
Cancer Institute, 9609 Medical Center Drive, Room 7W236, Rockville, 
MD 20892-9750, 240-276-5264, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21: SEP-6.
    Date: November 9, 2016.
    Time: 8:30 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W608, Rockville, MD 20892-9750, 240-276-6458, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: August 19, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-20346 Filed 8-24-16; 8:45 am]
 BILLING CODE 4140-01-P